Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,934 articles
Eton Pharmaceuticals (NASDAQ:ETON) Hits New 52-Week High After Analyst Upgrade
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report)’s share price hit a new 52-week high during trading on Monday after Zacks...
uniQure (NASDAQ:QURE) Shares Down 4.9% After Analyst Downgrade
uniQure N.V. (NASDAQ:QURE – Get Free Report) traded down 4.9% on Monday after Barclays lowered their price target on the stock from $31.00 to...
Celldex Therapeutics (NASDAQ:CLDX) Hits New 52-Week High on Analyst Upgrade
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday after Wolfe...
Clover Health Investments (NASDAQ:CLOV) Reaches New 52-Week Low on Analyst Downgrade
Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday...
Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Stock Price Down 9.2% – Here’s What Happened
Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shares fell 9.2% during mid-day trading on Monday . The stock traded as low as...
GSK (LON:GSK) Insider Wendy Becker Purchases 411 Shares
GSK plc (LON:GSK – Get Free Report) insider Wendy Becker purchased 411 shares of the stock in a transaction on Friday, March 20th. The shares...
Stock Traders Purchase High Volume of IDEAYA Biosciences Put Options (NASDAQ:IDYA)
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) was the recipient of unusually large options trading activity on Monday. Investors...
GSK (LON:GSK) Insider Jonathan Symonds Buys 5,000 Shares
GSK plc (LON:GSK – Get Free Report) insider Jonathan Symonds purchased 5,000 shares of the stock in a transaction dated Friday, March 20th. The...
GSK (LON:GSK) Insider Anne Beal Acquires 196 Shares of Stock
GSK plc (LON:GSK – Get Free Report) insider Anne Beal acquired 196 shares of GSK stock in a transaction that occurred on Friday, March 20th....
Investors Buy Large Volume of Put Options on WAVE Life Sciences (NASDAQ:WVE)
WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) was the recipient of some unusual options trading activity on Monday. Stock traders...
RGNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In REGENXBIO To Contact Him...
GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
GEHC gains FDA nod for Photonova Spectra, a next-gen photon-counting CT system to boost diagnostic precision, workflow efficiency and imaging...
GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
GEHC gains FDA nod for Photonova Spectra, a next-gen photon-counting CT system to boost diagnostic precision, workflow efficiency and imaging...
GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
GEHC gains FDA nod for Photonova Spectra, a next-gen photon-counting CT system to boost diagnostic precision, workflow efficiency and imaging...
GE HealthCare Wins FDA 510(k) Clearance for Photonova Spectra PCCT
GEHC gains FDA nod for Photonova Spectra, a next-gen photon-counting CT system to boost diagnostic precision, workflow efficiency and imaging...
📰
Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 24, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 4, 2026 deadline to...
Analysts Set Hyperfine, Inc. (NASDAQ:HYPR) Price Target at $1.45
Hyperfine, Inc. (NASDAQ:HYPR – Get Free Report) has earned a consensus rating of “Hold” from the five brokerages that are covering...
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives $53.00 Consensus PT from Brokerages
vTv Therapeutics Inc. (NASDAQ:VTVT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six...
Brokerages Set Cronos Group Inc. (NASDAQ:CRON) Target Price at $2.30
Cronos Group Inc. (NASDAQ:CRON – Get Free Report) has received an average rating of “Hold” from the five analysts that are covering...
High Tide Inc. (NASDAQ:HITI) Receives $6.13 Consensus Target Price from Analysts
High Tide Inc. (NASDAQ:HITI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five research...
QURE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UniQure To Contact Him...
RARE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him...
📰
INSP vs. HIMS: Which Stock Should Value Investors Buy Now?
INSP vs. HIMS: Which Stock Is the Better Value Option?
📰
INSP vs. HIMS: Which Stock Should Value Investors Buy Now?
INSP vs. HIMS: Which Stock Is the Better Value Option?
📰
CSLLY or ARGX: Which Is the Better Value Stock Right Now?
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
📰
CSLLY or ARGX: Which Is the Better Value Stock Right Now?
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
📰
akoyaGO Names Mark Montoya CEO to Lead Next Era of Technology-Driven Impact
akoyaGO has named Mark Montoya Chief Executive Officer to lead its next phase of growth as foundations increasingly turn to technology to drive...
ZYXIQ SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly...
MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Mereo BioPharma To Contact Him...
Conifer Health and Healthcare Systems of America Announce Enterprise Revenue Cycle Outsourcing Partnership
Multi-year agreement brings advanced technology, operational scale, and performance-driven revenue cycle best practices to hospitals across three...
PMI SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Picard Medical (PMI) Investors of Securities Class Action Deadline on April 13, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Picard Medical To Contact Him...
POM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Pomdoctor To Contact Him...
Amazon Unleashes Zoox Robotaxis In Austin And Miami To Challenge Waymo Dominance
Amazon.com Inc’s (NASDAQ:AMZN) Zoox is preparing to expand its robotaxi service to select members of the public in Austin and Miami later this...
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly...
📰
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare...
📰
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare...
📰
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity
Boston Scientific's pending trial results could help to drive sales growth for years to come after lower-than-expected sales forecasts.
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth
NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on...
What's Going On With 20/20 Biolabs Stock?
Shares of 20/20 Biolabs, Inc. (NASDAQ:AIDX) are trading lower Tuesday after the company announced that it entered into an exclusive U.S. technology...
Anti-Aging Protein Research Takes a Step Forward with Cell Cloning
Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- Equity-Insider.com — A protein called α-Klotho circulating in the...
ImmunityBio Crashes On FDA Warning Over Anktiva Claims
ImmunityBio, Inc. (NASDAQ:IBRX) shares are trading lower after the FDA issued a warning to the company over misleading Anktiva...
Board Member At Agilent Technologies Buys $241K of Stock
It was revealed in a recent SEC filing that DOW WILSON, Board Member at Agilent Technologies (NYSE:A) made a noteworthy insider purchase on March...
Eye On Growth: Dr. Scangos Adds $359K Of Agilent Technologies Stock To Portfolio
Dr. Scangos, Director at Agilent Technologies (NYSE:A), reported an insider buy on March 23, according to a new SEC filing.
What Happened:...
Director Of Agilent Technologies Purchased $340K In Stock
A significant insider buy by Otis W Brawley, Director at Agilent Technologies (NYSE:A), was executed on March 23, and reported in the recent SEC...
Bullish Move: Sue Rataj Shows Confidence, Acquires $241K In Agilent Technologies Stock
On March 23, Sue Rataj, Director at Agilent Technologies (NYSE:A) executed a significant insider buy, as disclosed in the latest SEC filing.
What...
GIGABYTE AORUS Partners with VALORANT Esports EMEA
GIGABYTE AORUS will support the VALORANT Champions Tour EMEA and Game Changers EMEA during the 2026 and 2027 seasons. The hardware sponsorship...